Overview
Evidence-based recommendations on procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay).
Last reviewed: 7 October 2015
Diagnostics guidance 18 has been migrated to HealthTech guidance 386. The recommendations and accompanying content remain unchanged.
Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.